We found variable BRCA1 protein immunostaining in tumor cell nuclei in frozen tissue sections with the AP16 and K-18 antibodies and with the MS110 antibody in contiguous FFPE tissues of randomly selected breast carcinomas (Table 1, Figures 1,2,3,4,5,6 and7). Here, BRCA1 is linked to neoplasm.